This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
H1N1 | 3560 |
Influenza | 3509 |
H5N1 | 2735 |
⁄ | 2369 |
HA | 2197 |
A | 2071 |
nan | 1094 |
RSV | 1079 |
Health | 1049 |
PCR | 951 |
RNA | 942 |
H3N2 | 871 |
T | 836 |
IAV | 801 |
ILI | 773 |
C | 757 |
United | 738 |
Hong | 724 |
States | 723 |
China | 701 |
B | 696 |
Kong | 681 |
SARS | 650 |
• | 543 |
Table | 543 |
Fig | 539 |
Pandemic | 529 |
oseltamivir | 503 |
RT | 453 |
van | 452 |
H7N9 | 437 |
US | 422 |
World | 416 |
National | 403 |
Virus | 378 |
CDC | 365 |
USA | 356 |
M2 | 354 |
Asia | 354 |
zanamivir | 343 |
H9N2 | 332 |
M | 331 |
een | 329 |
Disease | 328 |
Control | 326 |
Organization | 322 |
A(H1N1)pdm09 | 320 |
CD8 | 306 |
WHO | 303 |
Europe | 302 |
NP | 301 |
A(H1N1 | 301 |
H5 | 299 |
COVID-19 | 298 |
IFN | 295 |
Research | 292 |
Prevention | 280 |
CI | 275 |
Institute | 274 |
ICU | 268 |
New | 266 |
April | 265 |
II | 264 |
Australia | 261 |
LAIV | 259 |
Committee | 251 |
Africa | 247 |
pH1N1 | 246 |
Japan | 245 |
sha | 241 |
M1 | 241 |
UK | 239 |
het | 239 |
Vaccine | 235 |
MDCK | 235 |
H3 | 233 |
Human | 228 |
Department | 227 |
CD4 | 225 |
HI | 222 |
influenza | 218 |
South | 216 |
mg | 213 |
parainfluenza | 207 |
HPAI | 198 |
CoV-2 | 197 |
Flu | 196 |
H1N1pdm | 190 |
amantadine | 188 |
December | 188 |
University | 185 |
International | 185 |
Diseases | 184 |
H2N2 | 180 |
NS | 180 |
October | 180 |
Infectious | 179 |
SARI | 178 |
U.S. | 177 |
California | 177 |
haemagglutinin | 176 |
September | 176 |
Germany | 176 |
Public | 175 |
Russia | 175 |
H1 | 174 |
East | 173 |
Canada | 173 |
Medical | 172 |
DOI | 172 |
HIV | 170 |
May | 169 |
PB2 | 169 |
Surveillance | 169 |
der | 169 |
July | 168 |
Centers | 167 |
Study | 165 |
Immunization | 165 |
ARDS | 165 |
S. | 164 |
America | 164 |
Mexico | 161 |
S | 161 |
Oseltamivir | 161 |
HAI | 160 |
Thailand | 160 |
N | 159 |
Hospital | 159 |
Center | 159 |
January | 158 |
Group | 157 |
Global | 156 |
TCID | 155 |
England | 154 |
TNF | 153 |
sera | 152 |
Netherlands | 150 |
June | 149 |
November | 147 |
NAI | 147 |
ELISA | 147 |
Brazil | 147 |
HLA | 145 |
M2e | 145 |
Neuraminidase | 144 |
ARI | 144 |
C. | 144 |
System | 143 |
North | 143 |
HEF | 143 |
H7 | 143 |
West | 142 |
A(H3N2 | 139 |
Victoria | 139 |
PB1-F2 | 138 |
F | 138 |
Northern | 137 |
Vietnam | 136 |
Evaluation | 136 |
Effectiveness | 135 |
France | 134 |
J | 132 |
PA | 131 |
pH | 130 |
meta | 129 |
IIV | 129 |
Figure | 127 |
CoV | 127 |
Viral | 126 |
H7N7 | 126 |
Safety | 123 |
K | 123 |
MSC | 122 |
IgA | 122 |
March | 121 |
Avian | 121 |
IV | 120 |
IC | 119 |
I | 119 |
H2 | 117 |
Association | 116 |
IL-6 | 116 |
Advisory | 115 |
A(H5N1 | 115 |
H9 | 115 |
Republic | 113 |
Ministry | 113 |
D | 113 |
Care | 113 |
pandemic | 112 |
voor | 112 |
Respiratory | 112 |
Development | 111 |
nucleoprotein | 110 |
PR8 | 110 |
Efficacy | 110 |
PIKA | 108 |
February | 107 |
European | 107 |
COPD | 107 |
M. | 107 |
vivo | 107 |
I. | 106 |
MS | 106 |
Korea | 106 |
Hemisphere | 104 |
te | 103 |
Vaccines | 103 |
Seasonal | 103 |
L. | 103 |
Cambodia | 103 |
B. | 103 |
India | 102 |
Laboratory | 102 |
PBS | 101 |
Viruses | 99 |
Spain | 99 |
en | 98 |
FDA | 98 |
Beijing | 98 |
HA1 | 97 |
Impact | 97 |
Yamagata | 96 |
Practices | 95 |
Clinical | 95 |
A(H7N9 | 95 |
Southern | 95 |
Virology | 94 |
IFITM3 | 94 |
Protection | 92 |
Analysis | 92 |
August | 92 |
Swine | 92 |
VE | 92 |
el | 92 |
rimantadine | 91 |
Staphylococcus | 91 |
DNA | 91 |
City | 90 |
PB1 | 90 |
Nile | 90 |
S1 | 90 |
von | 90 |
mRNA | 90 |
aa | 89 |
Egypt | 89 |
Hajj | 89 |
Novel | 88 |
Medicine | 88 |
CA | 88 |
Network | 87 |
III | 87 |
G | 86 |
Review | 86 |
bij | 85 |
baloxavir | 85 |
Society | 84 |
Moscow | 84 |
Middle | 84 |
H. | 84 |
Centre | 83 |
EVs | 83 |
Ebola | 83 |
Taiwan | 83 |
USSR | 82 |
metapneumovirus | 81 |
del | 81 |
Russian | 81 |
IgG | 81 |
De | 81 |
CT | 81 |
Council | 80 |
zijn | 80 |
PIV | 80 |
Information | 79 |
HA2 | 79 |
Immunogenicity | 78 |
H1N1v | 78 |
Congo | 78 |
Eurasia | 77 |
TIV | 77 |
Italy | 77 |
TM | 77 |
virus | 77 |
Sciences | 76 |
Rapid | 75 |
Office | 75 |
MRC | 75 |
TLR3 | 75 |
H | 74 |
Aedes | 74 |
Shanghai | 74 |
ml | 74 |
General | 74 |
dat | 73 |
Union | 73 |
State | 73 |
Orthomyxoviridae | 73 |
MERS | 73 |
IL-10 | 73 |
Bunyaviridae | 73 |
NF | 72 |
HCWs | 72 |
R | 72 |
Science | 72 |
La | 71 |
J. | 71 |
H5N2 | 71 |
H275Y | 71 |
American | 71 |
ACIP | 71 |
London | 71 |
Hemagglutinin | 70 |
Dr. | 70 |
Protein | 70 |
Report | 70 |
VN | 69 |
Survey | 69 |
Risk | 69 |
Ontario | 69 |
Infection | 69 |
IVE | 69 |
Cross | 68 |
Studies | 68 |
Use | 68 |
Vaccination | 68 |
un | 67 |
Province | 67 |
Pathogenesis | 67 |
NS2 | 67 |
Molecular | 67 |
Epidemiology | 67 |
Siberia | 66 |
Turkey | 66 |
Structure | 66 |
Sea | 66 |
MVA | 66 |
Inc. | 66 |
Central | 66 |
Fisher | 65 |
Assessment | 65 |
Zealand | 65 |
α | 65 |
Ethics | 64 |
Poisson | 64 |
Respir | 64 |
WNV | 64 |
op | 63 |
Services | 63 |
HRV | 63 |
Animal | 63 |
Administration | 63 |
kg | 62 |
Ixodes | 62 |
Agency | 62 |
A/ | 62 |
< | 62 |
Data | 61 |
TMPRSS2 | 61 |
PM | 61 |
Drug | 61 |
des | 61 |
worden | 61 |
Ò | 61 |
E. | 60 |
Crimean | 60 |
glycyrrhizin | 60 |
Eastern | 60 |
NK | 60 |
War | 59 |
Qiagen | 59 |
Mortality | 59 |
Management | 59 |
Isolation | 59 |
Illness | 59 |
H1N1pdm09 | 59 |
Wales | 58 |
Transmission | 58 |
Southeast | 58 |
Response | 58 |
Kingdom | 58 |
Government | 58 |
ERK | 58 |
los | 58 |
Detection | 57 |
wordt | 57 |
Invitrogen | 57 |
tot | 56 |
York | 56 |
TBEV | 56 |
Singapore | 56 |
Program | 56 |
PICU | 56 |
P. | 56 |
MISMS | 56 |
MF59 | 56 |
Antiwei | 56 |
lg | 55 |
D. | 55 |
Food | 54 |
Infections | 54 |
NIAID | 54 |
BD | 54 |
Kazakhstan | 54 |
SNP | 54 |
Phase | 54 |
Zanamivir | 54 |
Working | 54 |
Poland | 54 |
Nairovirus | 53 |
CSF | 53 |
Community | 53 |
Adults | 53 |
RdRp | 53 |
Smith | 53 |
WT | 53 |
α2 | 53 |
| | 52 |
es | 52 |
Universal | 52 |
Roche | 52 |
LPS | 52 |
IBV | 52 |
H7N3 | 52 |
A. | 52 |
Healthcare | 51 |
Applied | 51 |
Box | 51 |
Scientific | 51 |
SA | 51 |
para | 51 |
R. | 50 |
Cell | 50 |
Effect | 50 |
Emergency | 50 |
N1 | 50 |
Indonesia | 50 |
ROS | 50 |
Service | 50 |
Volga | 50 |
inosine | 50 |
pdmH1N1 | 50 |
LTZ | 49 |
CTL | 49 |
Far | 49 |
Great | 49 |
H5N3 | 49 |
Investigation | 49 |
pranobex | 49 |
NEP | 49 |
Taxonomy | 49 |
Treatment | 49 |
den | 49 |
Plan | 49 |
Journal | 48 |
Australian | 48 |
BEVS | 48 |
Ixodidae | 48 |
NI | 48 |
Syndrome | 48 |
VLP | 48 |
aan | 48 |
MHC | 47 |
A&B | 47 |
BMI | 47 |
Children | 47 |
Finland | 47 |
LPAI | 47 |
Li | 47 |
deze | 47 |
Mongolia | 47 |
SRH | 47 |
Spanish | 47 |
V | 47 |
endosomal | 47 |
patiënt | 47 |
Epidemic | 46 |
Island | 46 |
HMPV | 46 |
Krai | 46 |
Chen | 46 |
CM2 | 46 |
MA | 46 |
LRTI | 46 |
MDV | 46 |
MD | 46 |
SNPs | 46 |
SPSS | 46 |
influenzapandemie | 46 |
mit | 46 |
niet | 46 |
rHA | 46 |
NAT | 45 |
Coronavirus | 45 |
Immune | 45 |
Kenya | 45 |
MOI | 45 |
Dis | 45 |
NIH | 45 |
Receptor | 45 |
Regional | 45 |
SP | 45 |
γ | 45 |
pandemie | 45 |
Antibody | 44 |
Chikungunya | 44 |
Fast | 44 |
Foundation | 44 |
L | 44 |
Lee | 44 |
MRSA | 44 |
River | 44 |
eine | 44 |
LoS | 43 |
Burden | 43 |
College | 43 |
DAS181 | 43 |
Ghana | 43 |
Ifitm3 | 43 |
Het | 43 |
MEK | 43 |
durch | 43 |
RV | 43 |
Trm | 43 |
Wang | 43 |
Western | 43 |
RBS | 43 |
Malaysia | 42 |
AAV | 42 |
CMV | 42 |
DMEM | 42 |
GISRS | 42 |
Legionella | 42 |
Life | 42 |
MP | 42 |
Host | 42 |
Mycoplasma | 42 |
Sigma | 42 |
Streptococcus | 42 |
U | 42 |
hpi | 42 |
kan | 42 |
zu | 42 |
OSV | 42 |
K. | 41 |
Appendix | 41 |
Astrakhan | 41 |
Caspian | 41 |
H274Y | 41 |
Region | 41 |
Mechanism | 41 |
Mediterranean | 41 |
Vero | 41 |
adamantane | 41 |
las | 41 |
SAS | 40 |
Amantadine | 40 |
HIV-1 | 40 |
Nanopore | 40 |
AIDS | 40 |
TLR | 40 |
middelen | 40 |
pdm09 | 40 |
Zambia | 40 |
Norway | 39 |
BALB | 39 |
Biosystems | 39 |
GenBank | 39 |
Med | 39 |
Lung | 39 |
Paulo | 39 |
RTI | 39 |
W. | 39 |
allantoic | 39 |
influenzavirus | 39 |
laninamivir | 39 |
ISKV | 38 |
ALI | 38 |
British | 38 |
Ct | 38 |
Darby | 38 |
GMT | 38 |
Gc | 38 |
H1N2 | 38 |
als | 38 |
Programme | 38 |
Uukuniemi | 38 |
door | 38 |
kappaB | 38 |
peramivir | 38 |
una | 38 |
± | 38 |
School | 38 |
MF59-adjuvanted | 37 |
Pathology | 37 |
Pacific | 37 |
Madin | 37 |
Academy | 37 |
IQR | 37 |
Board | 37 |
AOM | 37 |
RAPIDD | 37 |
Preparedness | 37 |
Webster | 37 |
Soviet | 37 |
URT | 37 |
antiinfluenza | 37 |
bei | 37 |
dan | 37 |
doc_id | 37 |
hemagglutinin | 37 |
rRT | 37 |
und | 37 |
Team | 37 |
DFA | 36 |
Guillain | 36 |
Gn | 36 |
ED | 36 |
Arboviruses | 36 |
DC | 36 |
CNS | 36 |
Brisbane | 36 |
Israel | 36 |
HK | 36 |
Project | 36 |
NHS | 36 |
RVP | 36 |
S2 | 36 |
SLPI | 36 |
Sofia | 36 |
Statistics | 36 |
Technologies | 36 |
om | 36 |
patiënten | 36 |
CE | 35 |
Emergence | 35 |
El | 35 |
Dengue | 35 |
DCs | 35 |
Critical | 35 |
Chinese | 35 |
H6N1 | 35 |
Biotechnology | 35 |
Antiviral | 35 |
Ann | 35 |
Allergy | 35 |
Alere | 35 |
Adenovirus | 35 |
Genoa | 35 |
Model | 35 |
Healthy | 35 |
Sentinel | 35 |
John | 35 |
® | 35 |
antivirale | 35 |
Toll | 35 |
Subbarao | 35 |
St. | 35 |
Texas | 35 |
San | 35 |
N2 | 35 |
¼ | 35 |
Melbourne | 35 |
Luminex | 35 |
Lake | 35 |
PIV3 | 34 |
EV | 34 |
Federation | 34 |
G. | 34 |
GP | 34 |
HSCT | 34 |
InfA | 34 |
Reference | 34 |
Pasteur | 34 |
Population | 34 |
SIVE | 34 |
SwIV | 34 |
Time | 34 |
heterologous | 34 |
PR | 33 |
Ae | 33 |
Argas | 33 |
District | 33 |
Genome | 33 |
Laboratories | 33 |
Liu | 33 |
MC | 33 |
N95 | 33 |
Oxford | 33 |
RNP | 33 |
Q | 33 |
Sweden | 33 |
Toronto | 33 |
Type | 33 |
Van | 33 |
X | 33 |
baculovirus | 33 |
i | 33 |
swine | 33 |
Institutes | 32 |
Age | 32 |
Bio | 32 |
CPE | 32 |
FluMist | 32 |
Georgia | 32 |
Identification | 32 |
NIC | 32 |
NS1 | 32 |
OC43 | 32 |
Social | 32 |
Staph | 32 |
Zika | 32 |
lymphopenia | 32 |
Culex | 31 |
Joint | 31 |
H6 | 31 |
H4 | 31 |
ER | 31 |
AI | 31 |
Anopheles | 31 |
ATP | 31 |
O. | 31 |
AA | 31 |
MOH | 31 |
Origin | 31 |
Omsk | 31 |
ist | 31 |
pp | 31 |
nan | 31 |
multicentre | 31 |
sind | 31 |
heterosubtypic | 31 |
Viren | 31 |
Set | 31 |
RH | 31 |
JEV | 30 |
AQI | 30 |
Arizona | 30 |
Chi | 30 |
Cochrane | 30 |
Diagnostics | 30 |
Duck | 30 |
Gene | 30 |
30 | |
HHS | 30 |
Hyalomma | 30 |
Islands | 30 |
zal | 30 |
Nature | 30 |
ORF | 30 |
SINV | 30 |
Summary | 30 |
Supplementary | 30 |
Tamiflu | 30 |
Vectors | 30 |
att | 30 |
werden | 30 |
MN | 30 |
E | 29 |
Laidlaw | 29 |
Hosts | 29 |
GlaxoSmithKline | 29 |
EC | 29 |
Madrid | 29 |
Bhanja | 29 |
Assay | 29 |
Argasidae | 29 |
Access | 29 |
8) | 29 |
MI | 29 |
das | 29 |
Michael | 29 |
Systems | 29 |
Organisation | 29 |
sich | 29 |
heeft | 29 |
TAMV | 29 |
Technology | 29 |
S3 | 29 |
Reye | 29 |
PubMed | 29 |
Primorsky | 29 |
ITIS | 28 |
Peter | 28 |
Ornithodoros | 28 |
Microsoft | 28 |
MMDS | 28 |
Index | 28 |
AE | 28 |
IL-1 | 28 |
DR | 28 |
Case | 28 |
Associated | 28 |
Primary | 28 |
Pneumonia | 28 |
P&I | 28 |
RNAseq | 28 |
antisera | 28 |
RR | 28 |
zich | 28 |
sentinel | 28 |
ein | 28 |
du | 28 |
le | 28 |
Zhang | 28 |
Unit | 28 |
UUKV | 28 |
TYUV | 28 |
−/− | 28 |
T. | 28 |
Britain | 27 |
Golgi | 27 |
F. | 27 |
David | 27 |
Collins | 27 |
Catalonia | 27 |
CCHFV | 27 |
Bureau | 27 |
Abstract | 27 |
Barr | 27 |
BATV | 27 |
Asian | 27 |
Arthropod | 27 |
Argentina | 27 |
Air | 27 |
HPIV | 27 |
Gordon | 27 |
Fletcher | 27 |
IL-2 | 27 |
SDS | 27 |
kunnen | 27 |
Institutional | 27 |
con | 27 |
bronchoalveolar | 27 |
Tahyna | 27 |
T2DM | 27 |
Synthesis | 27 |
TCM | 27 |
SD | 27 |
Phlebovirus | 27 |
PLoS | 27 |
NP+M1 | 27 |
McCullers | 27 |
MENA | 27 |
Ltd | 27 |
IL-15 | 26 |
Meta | 26 |
Lancet | 26 |
LRT | 26 |
NL63 | 26 |
Inhibition | 26 |
Induction | 26 |
IgM | 26 |
IL-8 | 26 |
Black | 26 |
Hantavirus | 26 |
Gluc | 26 |
Epstein | 26 |
Emerging | 26 |
Diagnostic | 26 |
CXR | 26 |
CASV | 26 |
Atlanta | 26 |
Panel | 26 |
Panama | 26 |
James | 26 |
Parainfluenza | 26 |
kB | 26 |
tijdens | 26 |
symptomen | 26 |
rt | 26 |
qRT | 26 |
ng | 26 |
na | 26 |
monocyte | 26 |
mogelijk | 26 |
zur | 26 |
hepatitis | 26 |
Phylogenetic | 26 |
auch | 26 |
Paul | 26 |
Philippines | 26 |
Patient | 26 |
Ref | 26 |
Viet | 26 |
W | 26 |
Taubenberger | 26 |
Corporation | 25 |
G1 | 25 |
FLU | 25 |
Dutch | 25 |
Deze | 25 |
Death | 25 |
Database | 25 |
Cyprus | 25 |
Creative | 25 |
Commons | 25 |
Comparison | 25 |
Chronic | 25 |
Chlamydia | 25 |
Biological | 25 |
Bei | 25 |
AS03 | 25 |
A2 | 25 |
Guidelines | 25 |
CYSTUS052 | 25 |
GSK | 25 |
Lithuania | 25 |
V. | 25 |
MDS | 25 |
β | 25 |
tegen | 25 |
marboxil | 25 |
carboxylate | 25 |
auf | 25 |
association | 25 |
White | 25 |
lm | 25 |
TCR | 25 |
SIV | 25 |
Robert | 25 |
Practice | 25 |
PPV | 25 |
NIRV | 25 |
Software | 25 |
Maria | 25 |
Hayden | 24 |
Glycyrrhizin | 24 |
HA0 | 24 |
HAT | 24 |
HCV | 24 |
Immunity | 24 |
Hien | 24 |
IL | 24 |
Ivanovsky | 24 |
GM | 24 |
Geneva | 24 |
Ankara | 24 |
Flavivirus | 24 |
Comparative | 24 |
Columbia | 24 |
Collection | 24 |
Chicago | 24 |
CHIKV | 24 |
NCR | 24 |
Antibodies | 24 |
Act | 24 |
ARD | 24 |
Matrix | 24 |
Azerbaijan | 24 |
Nam | 24 |
Thomas | 24 |
PPP | 24 |
ν | 24 |
protein | 24 |
picornavirus | 24 |
medRxiv | 24 |
intranasal | 24 |
huisarts | 24 |
hMPV | 24 |
geen | 24 |
Trends | 24 |
simplex | 24 |
Tetra | 24 |
Reporting | 24 |
TLR4 | 24 |
Pediatric | 24 |
Puerto | 24 |
Recommendations | 24 |
Portugal | 24 |
Sao | 24 |
Saudi | 24 |
Scotland | 24 |
Short | 24 |
Infektionen | 23 |
Depression | 23 |
Illumina | 23 |
H3N8 | 23 |
Guangdong | 23 |
First | 23 |
Family | 23 |
Factors | 23 |
Directigen | 23 |
Arabia | 23 |
Copenhagen | 23 |
Classification | 23 |
CHIMV | 23 |
Baloxavir | 23 |
BM2 | 23 |
Antigenic | 23 |
Anatolia | 23 |
AOR | 23 |
MSPL | 23 |
Ltd. | 23 |
Jong | 23 |
NIMR | 23 |
Text | 23 |
° | 23 |
nicht | 23 |
hebben | 23 |
grippe | 23 |
einer | 23 |
aviaire | 23 |
anti | 23 |
URTI | 23 |
gripe | 23 |
TRAIL | 23 |
Sanofi | 23 |
S4 | 23 |
Raf | 23 |
RCT | 23 |
Pearson | 23 |
PR/8/34 | 23 |
PKR | 23 |
Season | 23 |
Green | 22 |
Fund | 22 |
GCV | 22 |
GIP | 22 |
GPs | 22 |
Generation | 22 |
ID | 22 |
H10N8 | 22 |
H7N2 | 22 |
Hepatitis | 22 |
InfB | 22 |
Federal | 22 |
Fluor | 22 |
Alaska | 22 |
Excellence | 22 |
EID | 22 |
Defense | 22 |
DENF | 22 |
Census | 22 |
Binding | 22 |
Bij | 22 |
Anas | 22 |
An | 22 |
Kul | 22 |
Activity | 22 |
AH | 22 |
Issyk | 22 |
heterotypic | 22 |
Leningrad | 22 |
Yang | 22 |
≥65 | 22 |
Les | 22 |
serocomplex | 22 |
rhinorrhea | 22 |
ook | 22 |
neuraminidase | 22 |
mid | 22 |
mRNAs | 22 |
chemoprophylaxis | 22 |
arboviruses | 22 |
actividad | 22 |
Z | 22 |
su | 22 |
Washington | 22 |
SGA | 22 |
Murphy | 22 |
VII | 22 |
Nelson | 22 |
Neu5Ac | 22 |
PAGE | 22 |
People | 22 |
Sakhalin | 22 |
Single | 22 |
Strategy | 22 |
Ukraine | 22 |
LTZs | 21 |
IRF3 | 21 |
Incidence | 21 |
KHAV | 21 |
LD | 21 |
Outbreak | 21 |
MCP-1 | 21 |
Nigeria | 21 |
OHFV | 21 |
Heterosubtypic | 21 |
PyroScript | 21 |
IDO | 21 |
Conference | 21 |
HE | 21 |
HBC | 21 |
Excel | 21 |
Epidemiological | 21 |
Day | 21 |
Characterization | 21 |
Chan | 21 |
COX-2 | 21 |
Abs | 21 |
ARN | 21 |
AIV | 21 |
Quality | 21 |
QYBV | 21 |
Blood | 21 |
Queensland | 21 |
Y | 21 |
Reassortment | 21 |
oder | 21 |
mm | 21 |
kDa | 21 |
i.n | 21 |
fármacos | 21 |
dans | 21 |
como | 21 |
cellulaire | 21 |
Zhejiang | 21 |
Yuen | 21 |
herpes | 21 |
Writing | 21 |
SAKV | 21 |
Whitney | 21 |
Regulations | 21 |
Reverse | 21 |
RhoA | 21 |
S31N | 21 |
SHIVERS | 21 |
Supp | 21 |
Systematic | 21 |
TBE | 21 |
Watch | 21 |
EpiGraph | 20 |
H13 | 20 |
Evolution | 20 |
Experimental | 20 |
Flaviviridae | 20 |
GISAID | 20 |
Glycosylation | 20 |
Hungary | 20 |
HEF2 | 20 |
HFRS | 20 |
Haemaphysalis | 20 |
Herrler | 20 |
High | 20 |
IRR | 20 |
Discovery | 20 |
Eagle | 20 |
AUC | 20 |
Czech | 20 |
Cox | 20 |
Commission | 20 |
Century | 20 |
Centres | 20 |
CD14 | 20 |
CAP | 20 |
Barré | 20 |
BMC | 20 |
BHAV | 20 |
Anti | 20 |
Americas | 20 |
Kim | 20 |
ATCC | 20 |
A+B | 20 |
KHURV | 20 |
IRF7 | 20 |
Kyrgyzstan | 20 |
Singapore/97 | 20 |
São | 20 |
TND | 20 |
Viboud | 20 |
Weekly | 20 |
ZTV | 20 |
bocavirus | 20 |
cDNA | 20 |
ca | 20 |
coryza | 20 |
favipiravir | 20 |
klinische | 20 |
les | 20 |
pandemisch | 20 |
LDH | 20 |
− | 20 |
Syncytial | 20 |
ϩ | 20 |
Serologic | 20 |
Policy | 20 |
MEM | 20 |
Mann | 20 |
MetaMap | 20 |
NHG | 20 |
Pharmaceuticals | 20 |
NY | 20 |
QuickVue | 20 |
Red | 20 |
Reed | 20 |
Rights | 20 |
SH | 20 |
Security | 20 |
Sendai | 20 |
Grant | 19 |
EU | 19 |
Environmental | 19 |
Escherichia | 19 |
Framework | 19 |
GPSS | 19 |
ISSS | 19 |
H16 | 19 |
HCoV | 19 |
HPAIV | 19 |
Haemagglutinin | 19 |
IFN- | 19 |
ECDC | 19 |
Indian | 19 |
EGCG | 19 |
Biosciences | 19 |
DHOV | 19 |
Consultation | 19 |
Cold | 19 |
CSL | 19 |
CRP | 19 |
CD55 | 19 |
CC | 19 |
Biomedical | 19 |
Australians | 19 |
Army | 19 |
Application | 19 |
All | 19 |
Acute | 19 |
ANOVA | 19 |
JS | 19 |
JNK | 19 |
profylaxe | 19 |
Le | 19 |
Tokyo | 19 |
Lin | 19 |
à | 19 |
ty | 19 |
ou | 19 |
min | 19 |
i.m | 19 |
huésped | 19 |
disease | 19 |
contra | 19 |
Wu | 19 |
William | 19 |
UZAV | 19 |
Tyuleniy | 19 |
Tunisia | 19 |
die | 19 |
Sydney | 19 |
Publishing | 19 |
Switzerland | 19 |
Mechanisms | 19 |
Okhotsk | 19 |
Palese | 19 |
Peiris | 19 |
Pfeiffer | 19 |
MID | 19 |
RBC | 19 |
Rh | 19 |
Seattle | 19 |
Severe | 19 |
Springer | 19 |
HCW | 18 |
Genesis | 18 |
Genetic | 18 |
Getah | 18 |
Gly | 18 |
H10 | 18 |
H5N1-induced | 18 |
ISN | 18 |
IAR | 18 |
ICD-10 | 18 |
Fc | 18 |
IVIG | 18 |
Inhibitor | 18 |
Interaction | 18 |
Introduction | 18 |
Fujian | 18 |
Area | 18 |
FRI | 18 |
DENV | 18 |
Jun | 18 |
Belshe | 18 |
Broad | 18 |
Clin | 18 |
Clinic | 18 |
Congress | 18 |
DM | 18 |
English | 18 |
DMSO | 18 |
Division | 18 |
Dynamics | 18 |
EMA | 18 |
EV71 | 18 |
Economic | 18 |
JAK | 18 |
group | 18 |
Kit | 18 |
aglycoristocetin | 18 |
Tang | 18 |
Thermo | 18 |
Trust | 18 |
VAED | 18 |
Wright | 18 |
Year | 18 |
μg | 18 |
Stata | 18 |
por | 18 |
proteína | 18 |
tratamiento | 18 |
ts | 18 |
uit | 18 |
MDA5 | 18 |
Statistical | 18 |
Yu | 18 |
Sequencing | 18 |
P3 | 18 |
SI | 18 |
Martin | 18 |
Matrosovich | 18 |
Monitoring | 18 |
NSW | 18 |
Non | 18 |
P | 18 |
Nicholson | 18 |
Registry | 18 |
Relenza | 18 |
Rep | 18 |
Resistance | 18 |
SAR | 18 |
SHCLCI | 18 |
Guide | 17 |
IL-12 | 17 |
Guinea | 17 |
HKU1 | 17 |
Haemophilus | 17 |
Handbook | 17 |
Hum | 17 |
ICD | 17 |
Louis | 17 |
INKV | 17 |
ISCOM | 17 |
Inhibitors | 17 |
Intranasal | 17 |
Iran | 17 |
Ireland | 17 |
Jersey | 17 |
Greece | 17 |
Guidance | 17 |
Arbor/6/60 | 17 |
Glycan | 17 |
Belgium | 17 |
Aldrich | 17 |
Methods | 17 |
Arboviral | 17 |
Authority | 17 |
Background | 17 |
Bacteriology | 17 |
Baculovirus | 17 |
Charles | 17 |
Genetics | 17 |
Clara | 17 |
D.I. | 17 |
DCP | 17 |
Denmark | 17 |
Dix | 17 |
Dunkin | 17 |
Fort | 17 |
MAPK | 17 |
Los | 17 |
Microtus | 17 |
Wagner | 17 |
analysis | 17 |
andere | 17 |
antigen | 17 |
contacten | 17 |
han | 17 |
hemagglutinins | 17 |
novo | 17 |
ont | 17 |
par | 17 |
plasmacytoid | 17 |
series | 17 |
siRNA | 17 |
son | 17 |
st | 17 |
zou | 17 |
À1 | 17 |
Monto | 17 |
Wuhan | 17 |
jaar | 17 |
Vertebrate | 17 |
Pp | 17 |
UMLS | 17 |
NT | 17 |
Natural | 17 |
Nauka | 17 |
Open | 17 |
Pol | 17 |
Powassan | 17 |
Paper | 17 |
Prism | 17 |
SSR | 17 |
Standard | 17 |
Strategies | 17 |
TMPRSS13 | 17 |
Tecumseh | 17 |
Tijdens | 17 |
Gaussia | 16 |
IKK | 16 |
GeneXpert | 16 |
GmbH | 16 |
GraphPad | 16 |
HF | 16 |
House | 16 |
Huang | 16 |
Humoral | 16 |
Mucosal | 16 |
IP-10 | 16 |
Immunology | 16 |
Kaiser | 16 |
MOF | 16 |
MRI | 16 |
Memory | 16 |
Miller | 16 |
G9 | 16 |
GETV | 16 |
Activation | 16 |
Form | 16 |
Flublok | 16 |
Overview | 16 |
Adult | 16 |
BACKGROUND | 16 |
BALF | 16 |
BURV | 16 |
Barre | 16 |
BinaxNOW | 16 |
Biotech | 16 |
Blackwell | 16 |
C3 | 16 |
CXCL10 | 16 |
Canadian | 16 |
Culture | 16 |
Cx | 16 |
Cytotoxic | 16 |
DAD | 16 |
Djibouti | 16 |
Novartis | 16 |
Dr | 16 |
POWV | 16 |
Veterinary | 16 |
Welfare | 16 |
XTD | 16 |
beleid | 16 |
ces | 16 |
clarithromycin | 16 |
cytopenias | 16 |
da | 16 |
df | 16 |
kinderen | 16 |
molécules | 16 |
nucleocapsid | 16 |
p.i | 16 |
pandemische | 16 |
s. | 16 |
type | 16 |
une | 16 |
Peninsula | 16 |
virales | 16 |
mAbs | 16 |
Trials | 16 |
Rhinovirus | 16 |
Performance | 16 |
Territory | 16 |
Pregnancy | 16 |
ProCT | 16 |
Prophylaxis | 16 |
REIPI | 16 |
RVDSS | 16 |
Reactive | 16 |
Protective | 16 |
Richard | 16 |
Santa | 16 |
Section | 16 |
Senegal | 16 |
Star | 16 |
Rhinoviruses | 16 |
TLR7 | 16 |
Tables | 16 |
ICD-9-CM | 15 |
Khabarovsk | 15 |
Likelihood | 15 |
Library | 15 |
Lamb | 15 |
LOD | 15 |
Infektion | 15 |
Instituto | 15 |
Immunisation | 15 |
IRB | 15 |
Madagascar | 15 |
Limited | 15 |
Nrf2 | 15 |
Mainland | 15 |
Medicines | 15 |
Minister | 15 |
Mutations | 15 |
NAIs | 15 |
NIV | 15 |
NLRP3 | 15 |
Nuclear | 15 |
PPAR | 15 |
PRAMS | 15 |
Hospitalizations | 15 |
Humans | 15 |
CD16 | 15 |
Ham | 15 |
H14 | 15 |
Adamantane | 15 |
Aerosol | 15 |
Antigen | 15 |
Bangkok | 15 |
Biology | 15 |
CCHF | 15 |
Pfizer | 15 |
CFR | 15 |
CPV-2 | 15 |
Cancer | 15 |
Carolina | 15 |
Ceratixodes | 15 |
Chowell | 15 |
DPO | 15 |
Democratic | 15 |
Deutschland | 15 |
Dhori | 15 |
Diagnosis | 15 |
Director | 15 |
Ecology | 15 |
Fever | 15 |
GSH | 15 |
German | 15 |
Pan | 15 |
NZ | 15 |
Plague | 15 |
Tween | 15 |
Uganda | 15 |
Windows | 15 |
YK | 15 |
administration | 15 |
bescherming | 15 |
casos | 15 |
dagen | 15 |
dit | 15 |
dl | 15 |
echter | 15 |
eerste | 15 |
fase | 15 |
fusión | 15 |
health | 15 |
key | 15 |
meer | 15 |
national | 15 |
nog | 15 |
onder | 15 |
pneumococcus | 15 |
qPCR | 15 |
viral | 15 |
Plain | 15 |
UP | 15 |
␣ | 15 |
Tran | 15 |
Serfling | 15 |
Planning | 15 |
Products | 15 |
Raman | 15 |
Recognition | 15 |
Refluvac | 15 |
Res | 15 |
SISSS | 15 |
SYBR | 15 |
Sanger | 15 |
Sci | 15 |
S6 | 15 |
Sialic | 15 |
Tajikistan | 15 |
Student | 15 |
Thomson | 15 |
Thai | 15 |
Test | 15 |
Thoracic | 15 |
TMB | 15 |
TK | 15 |
TGF | 15 |
TAHV | 15 |
Total | 15 |
Level | 14 |
Glyprot | 14 |
HEF1 | 14 |
HIVE | 14 |
Household | 14 |
IAE | 14 |
IL-1b | 14 |
Industry | 14 |
Innovation | 14 |
Institut | 14 |
Integrated | 14 |
NLP | 14 |
Lvov | 14 |
MG | 14 |
Mass | 14 |
Meteorological | 14 |
Minor | 14 |
Myodes | 14 |
N. | 14 |
NAC | 14 |
NADPH | 14 |
NFκB | 14 |
NJ | 14 |
Fogarty | 14 |
Genomic | 14 |
County | 14 |
Fas | 14 |
Chotpitayasunondh | 14 |
A1 | 14 |
Agriculture | 14 |
Americans | 14 |
Arbidol | 14 |
Assembly | 14 |
Austria | 14 |
Basel | 14 |
Challenge | 14 |
Chemical | 14 |
Chlamydophila | 14 |
OR | 14 |
FIA | 14 |
Connecticut | 14 |
Dermacentor | 14 |
Diego | 14 |
Distemper | 14 |
ELISPOT | 14 |
EVOC | 14 |
Emerg | 14 |
Entry | 14 |
Epidemiol | 14 |
Expert | 14 |
Na | 14 |
einem | 14 |
Ottawa | 14 |
demostrado | 14 |
Uzbekistan | 14 |
WI | 14 |
WNF | 14 |
aantal | 14 |
acyclovir | 14 |
adamantanes | 14 |
behandeling | 14 |
caspase-3 | 14 |
cepas | 14 |
cytomegalovirus | 14 |
ij | 14 |
Trial | 14 |
infecties | 14 |
leiden | 14 |
multiorgan | 14 |
n.d | 14 |
neuraminidaseremmers | 14 |
nieuw | 14 |
pDCs | 14 |
proteínas | 14 |
zoals | 14 |
PIDIRAC | 14 |
Trivalent | 14 |
l'infection | 14 |
Treanor | 14 |
Rico/8/34 | 14 |
PPE | 14 |
Travel | 14 |
PRISMA | 14 |
Pathogenicity | 14 |
Pattern | 14 |
Polymerase | 14 |
RIDT | 14 |
Recombinant | 14 |
ResPlex | 14 |
Resources | 14 |
Petersburg | 14 |
Royal | 14 |
Transcaucasia | 14 |
Togaviridae | 14 |
Russell | 14 |
Station | 14 |
Sichuan | 14 |
Spearman | 14 |
Seeplex | 14 |
Second | 14 |
SPF | 14 |
SE | 14 |
ICMJE | 13 |
Int | 13 |
Initiative | 13 |
ISGs | 13 |
Interferon | 13 |
IL-1B | 13 |
IL-17 | 13 |
HDI | 13 |
Herfst | 13 |
HSV | 13 |
HN | 13 |
H1n1 | 13 |
H12 | 13 |
LEIV | 13 |
Gibson | 13 |
Interim | 13 |
Monte | 13 |
Labor | 13 |
Long | 13 |
Lyme | 13 |
Madison | 13 |
Mark | 13 |
Maryland | 13 |
McAuley | 13 |
MedImmune | 13 |
MoH | 13 |
Modeling | 13 |
NC | 13 |
Nepal | 13 |
Ninth | 13 |
Options | 13 |
Games | 13 |
Genbank | 13 |
BRD | 13 |
GBS | 13 |
Apodemus | 13 |
CS-8958 | 13 |
CL | 13 |
Bloom | 13 |
Bavaria | 13 |
Origanum | 13 |
BAL | 13 |
Alphavirus | 13 |
Full | 13 |
Airport | 13 |
Ageing | 13 |
AP-1 | 13 |
AEs | 13 |
ABI | 13 |
A(H1N1)v | 13 |
CSTE | 13 |
Cellular | 13 |
Ck | 13 |
Co. | 13 |
Cohen | 13 |
Corp. | 13 |
Coxsackie | 13 |
Crystal | 13 |
Delta | 13 |
Design | 13 |
Dit | 13 |
E2 | 13 |
Estimation | 13 |
Ethical | 13 |
FM/47 | 13 |
FasL | 13 |
Fildes | 13 |
Oral | 13 |
Lows | 13 |
P2 | 13 |
avons | 13 |
maar | 13 |
kann | 13 |
infectie | 13 |
für | 13 |
ferret | 13 |
bronchiolitis | 13 |
arthralgia | 13 |
Wong | 13 |
alle | 13 |
airways | 13 |
acetylneuraminic | 13 |
aber | 13 |
Xu | 13 |
Wurzer | 13 |
messeae | 13 |
nach | 13 |
personen | 13 |
preprint | 13 |
respiratoire | 13 |
sciIAVs | 13 |
square | 13 |
tds | 13 |
trans | 13 |
vaccin | 13 |
virale | 13 |
volgende | 13 |
ward | 13 |
wird | 13 |
‡1:40 | 13 |
−1 | 13 |
P4 | 13 |
Wood | 13 |
nous | 13 |
Wisconsin | 13 |
Qalyub | 13 |
S5 | 13 |
Rimantadine | 13 |
Resource | 13 |
Rad | 13 |
RV12 | 13 |
RUKV | 13 |
QIAamp | 13 |
SW | 13 |
Pseudomonas | 13 |
Promega | 13 |
Production | 13 |
Proceedings | 13 |
Wilcoxon | 13 |
Press | 13 |
SHAP | 13 |
R0 | 13 |
Togo | 13 |
Volgograd | 13 |
Virological | 13 |
VI | 13 |
Voor | 13 |
Times | 13 |
TMD | 13 |
TLRs | 13 |
Stevens | 13 |
Stephen | 13 |
Standards | 13 |
Sri | 13 |
Slovakia | 13 |
Simonsen | 13 |
Seoul | 13 |
Gilbert | 12 |
Girard | 12 |
Glasgow | 12 |
Eq | 12 |
Greater | 12 |
H11 | 12 |
GCN4 | 12 |
H5-VHHb | 12 |
Geiss | 12 |
Favipiravir | 12 |
Francisco | 12 |
Francis | 12 |
File | 12 |
Field | 12 |
Feng | 12 |
FLUBV | 12 |
Establishment | 12 |
HBV | 12 |
HAU | 12 |
Kawaoka | 12 |
Heart | 12 |
Jackson | 12 |
Enterovirus | 12 |
Lanka | 12 |
Lab | 12 |
Knowledge | 12 |
Karron | 12 |
KOMV | 12 |
Johnson | 12 |
Indigenous | 12 |
IDSA | 12 |
Ill | 12 |
IgG2a | 12 |
IVB | 12 |
IU | 12 |
IMCI | 12 |
IFITM | 12 |
IFA | 12 |
Environment | 12 |
Agenda | 12 |
Een | 12 |
Education | 12 |
CPMP | 12 |
CIs | 12 |
CAM | 12 |
Bunyamwera | 12 |
Brazilian | 12 |
Bocavirus | 12 |
Bayesian | 12 |
Based | 12 |
Arctic | 12 |
Annual | 12 |
Andrewes | 12 |
ATPase | 12 |
ASC | 12 |
AP | 12 |
ADV | 12 |
ACE2 | 12 |
3a | 12 |
Ca | 12 |
Candidate | 12 |
Capital | 12 |
Company | 12 |
ET | 12 |
ECMO | 12 |
DoD | 12 |
Distribution | 12 |
Der | 12 |
DOCX | 12 |
Core | 12 |
Communication | 12 |
Carlo | 12 |
Cohort | 12 |
Code | 12 |
Cocirculation | 12 |
Cleveland | 12 |
Circulation | 12 |
Choi | 12 |
Carlsbad | 12 |
M2SR | 12 |
MAP | 12 |
MCO | 12 |
TOSV | 12 |
celular | 12 |
bay | 12 |
Zambon | 12 |
Wolff | 12 |
Wilson | 12 |
Williams | 12 |
Wellcome | 12 |
WBC | 12 |
Virginia | 12 |
Veit | 12 |
Valley | 12 |
Valencia | 12 |
VIDRL | 12 |
VA | 12 |
Utah | 12 |
U. | 12 |
Tropical | 12 |
chez | 12 |
dem | 12 |
drie | 12 |
transcriptomique | 12 |
ML | 12 |
␥ | 12 |
в | 12 |
Ϫ | 12 |
κB | 12 |
één | 12 |
× | 12 |
sobre | 12 |
europaea | 12 |
siRNAs | 12 |
serologic | 12 |
rgVac1ins | 12 |
psittaci | 12 |
moet | 12 |
mensen | 12 |
gebruik | 12 |
TaqMan | 12 |
enza | 12 |
TLKV | 12 |
PPAbs | 12 |
PMT | 12 |
PIV-3 | 12 |
PAR2 | 12 |
Operational | 12 |
OHF | 12 |
Number | 12 |
Northeast | 12 |
Netflix | 12 |
Minnesota | 12 |
Microbiology | 12 |
Melero | 12 |
McIntosh | 12 |
Maximum | 12 |
Manual | 12 |
MPO | 12 |
MMR | 12 |
SuperScript | 12 |
PO | 12 |
NonSyn | 12 |
Pakistan | 12 |
Reid | 12 |
St | 12 |
Spring | 12 |
Sindbis | 12 |
Shope | 12 |
Selection | 12 |
Sa | 12 |
SHLCI | 12 |
Ribavirin | 12 |
Secretary | 12 |
QBIC | 12 |
QAIC | 12 |
Protocol | 12 |
Pre | 12 |
Potsdam | 12 |
QSS | 12 |
Patients | 12 |
IL-18 | 11 |
HPLC | 11 |
H8 | 11 |
HAI-05 | 11 |
HEPA | 11 |
Helsinki | 11 |
HTS | 11 |
HeLa | 11 |
H4N6 | 11 |
H5N6 | 11 |
Force | 11 |
Gibco | 11 |
Gezondheidsraad | 11 |
Gates | 11 |
GSRV | 11 |
GHOR | 11 |
GA | 11 |
Future | 11 |
Florida | 11 |
FluSure | 11 |
IL-27 | 11 |
IL-1β | 11 |
Mini | 11 |
ISG | 11 |
Low | 11 |
Ferrets | 11 |
Mono | 11 |
Mix | 11 |
Method | 11 |
Meeting | 11 |
Medicinal | 11 |
Master | 11 |
MFI | 11 |
Lu | 11 |
Lambert | 11 |
IX | 11 |
LT | 11 |
Koopmans | 11 |
Kingdon | 11 |
Kash | 11 |
Kalmyk | 11 |
Jiangsu | 11 |
Jerusalem | 11 |
JE | 11 |
Il | 11 |
Fields | 11 |
BKNV | 11 |
Ferguson | 11 |
Belarus | 11 |
CCR5 | 11 |
CAIV | 11 |
Brydak | 11 |
Bris/07 | 11 |
Bordetella | 11 |
Biosecurity | 11 |
Biosafety | 11 |
Bioline | 11 |
Berlin | 11 |
Batai | 11 |
Cases | 11 |
Bank | 11 |
BSL-3 | 11 |
Myc | 11 |
Astana | 11 |
Aegean | 11 |
Accra | 11 |
ARTSV | 11 |
AF03-adjuvanted | 11 |
A(H2N2 | 11 |
Cary | 11 |
Chanock | 11 |
FFP2 | 11 |
EW | 11 |
FBS | 11 |
Estimating | 11 |
Es | 11 |
Erreger | 11 |
Erkrankungen | 11 |
Eric | 11 |
Epidemiologic | 11 |
Endo | 11 |
Encephalitis | 11 |
EIP | 11 |
Chicken | 11 |
EIA | 11 |
Dose | 11 |
Delivery | 11 |
Declaration | 11 |
Davis | 11 |
Cruz | 11 |
Complex | 11 |
Commander | 11 |
Colombia | 11 |
Morens | 11 |
Koch | 11 |
N1-N9 | 11 |
Taylor | 11 |
human | 11 |
groot | 11 |
geeft | 11 |
geadviseerd | 11 |
est | 11 |
erythromycin | 11 |
enkele | 11 |
bis | 11 |
antiviral | 11 |
adenoviral | 11 |
aalge | 11 |
a2 | 11 |
Wuxi | 11 |
Wiley | 11 |
Wells | 11 |
Virol | 11 |
VTM | 11 |
U0126 | 11 |
Toscana | 11 |
Tick | 11 |
Thogotovirus | 11 |
hyperimmune | 11 |
informatie | 11 |
ingroup | 11 |
rs12252 | 11 |
≥38 | 11 |
NALT | 11 |
été | 11 |
zum | 11 |
wie | 11 |
waarin | 11 |
vi | 11 |
unión | 11 |
sont | 11 |
rgVac1sub | 11 |
mL | 11 |
range | 11 |
proceso | 11 |
pandemia | 11 |
ovo | 11 |
optreden | 11 |
obliterans | 11 |
nt | 11 |
naar | 11 |
membrana | 11 |
Therapy | 11 |
interferon | 11 |
TBHQ | 11 |
Origins | 11 |
RANTES | 11 |
Preliminary | 11 |
Poyang | 11 |
Philadelphia | 11 |
Peru | 11 |
Peramivir | 11 |
Pediatrics | 11 |
Patienten | 11 |
PACF | 11 |
Nucleoprotein | 11 |
ROC | 11 |
Novosibirsk | 11 |
Next | 11 |
Newcastle | 11 |
Nederland | 11 |
Nacional | 11 |
NYMC | 11 |
TA | 11 |
NSD5 | 11 |
NBER | 11 |
RMSE | 11 |
Pandemrix | 11 |
Randomized | 11 |
Se | 11 |
Sun | 11 |
Stockholm | 11 |
Stephenson | 11 |
Stem | 11 |
Spread | 11 |
Special | 11 |
Small | 11 |
Slovenia | 11 |
Sera | 11 |
Southeastern | 11 |
Susceptibility | 11 |
ST | 11 |
SRID | 11 |
SR | 11 |
SOKV | 11 |
S7 | 11 |
Role | 11 |
Regulation | 11 |
Rev | 11 |
Inc | 10 |
IRF-7 | 10 |
IgG1 | 10 |
IkappaB | 10 |
Immunother | 10 |
Jahren | 10 |
Independent | 10 |
Innate | 10 |
Jin | 10 |
Interventions | 10 |
IPMiner | 10 |
Intensive | 10 |
HRP | 10 |
ILC2 | 10 |
I38X | 10 |
Hygiene | 10 |
Houston | 10 |
Hemagglutination | 10 |
Hazara | 10 |
Hall | 10 |
HIV-2 | 10 |
HPS | 10 |
HPA | 10 |
Jordan | 10 |
HLH-04 | 10 |
Jonathan | 10 |
Measurement | 10 |
Kentucky | 10 |
Malta | 10 |
H15 | 10 |
Mountain | 10 |
Mitochondrial | 10 |
Microbiol | 10 |
Menschen | 10 |
Media | 10 |
McNemar | 10 |
McElhaney | 10 |
Mayo | 10 |
Matthew | 10 |
Mapping | 10 |
Macaca | 10 |
Krasnodar | 10 |
Maassab | 10 |
Ma | 10 |
MEDI-493 | 10 |
Lusaka | 10 |
Lipatov | 10 |
Lim | 10 |
Lau | 10 |
Larus | 10 |
LL-37 | 10 |
LBM | 10 |
Kruskal | 10 |
H5N1/97 | 10 |
BSA | 10 |
Guan | 10 |
BioMed | 10 |
Cells | 10 |
Caspase | 10 |
Cambridge | 10 |
CTLs | 10 |
CFA | 10 |
CD151 | 10 |
C2 | 10 |
Bulgaria | 10 |
Brown | 10 |
Biologicals | 10 |
Bioethics | 10 |
Bias | 10 |
Christmas | 10 |
Bcl-2 | 10 |
BUNV | 10 |
Andrew | 10 |
Alonso | 10 |
Alert | 10 |
Ag | 10 |
Adjuvant | 10 |
Action | 10 |
A/(H5N1 | 10 |
-80 | 10 |
NIs | 10 |
Cepheid | 10 |
Collaboration | 10 |
Groups | 10 |
FP | 10 |
Graham | 10 |
Glybera | 10 |
Garcia | 10 |
GROG | 10 |
GI | 10 |
GAR | 10 |
G6PD | 10 |
Frequency | 10 |
Foster | 10 |
FluBlØk | 10 |
FilmArray | 10 |
FFP1 | 10 |
Consensus | 10 |
Evolutionary | 10 |
España | 10 |
Elsevier | 10 |
EDs | 10 |
EA | 10 |
E3 | 10 |
Dulbecco | 10 |
Coronaviruses | 10 |
Copan | 10 |
Controlled | 10 |
Contribution | 10 |
NFkB | 10 |
flagellin | 10 |
NSs | 10 |
eosin | 10 |
leur | 10 |
können | 10 |
influenzalike | 10 |
inflammasome | 10 |
il | 10 |
iNO | 10 |
hyrcanus | 10 |
hematoxylin | 10 |
glycopeptide | 10 |
glareolus | 10 |
geven | 10 |
enteroviruses | 10 |
manifeste | 10 |
einen | 10 |
eficacia | 10 |
control | 10 |
complicaties | 10 |
committee | 10 |
cefuroxime | 10 |
bestaat | 10 |
bd | 10 |
author(s | 10 |
aus | 10 |
atra | 10 |
maanden | 10 |
miRNA | 10 |
a2,3 | 10 |
syndromic | 10 |
NTS | 10 |
≥40 | 10 |
−80 | 10 |
δ | 10 |
þ | 10 |
Übertragung | 10 |
wurden | 10 |
verspreiding | 10 |
veroorzaakt | 10 |
twee | 10 |
tickborne | 10 |
standaard | 10 |
mmol | 10 |
sciences | 10 |
ribonucleoproteins | 10 |
red | 10 |
qui | 10 |
putus | 10 |
perforin | 10 |
pdm | 10 |
ongeveer | 10 |
omdat | 10 |
nur | 10 |
nth | 10 |
acetyl | 10 |
multibasic | 10 |
Zheng | 10 |
Phalacrocorax | 10 |
Romania | 10 |
Reviews | 10 |
Rescue | 10 |
Replication | 10 |
RFI-641 | 10 |
Quebec | 10 |
Quaranfil | 10 |
Publisher | 10 |
Provincial | 10 |
Preparations | 10 |
Practitioners | 10 |
Part | 10 |
SI/06 | 10 |
PRRs | 10 |
PI3K | 10 |
PHE | 10 |
PAR-2 | 10 |
Outcomes | 10 |
Oregon | 10 |
Olea | 10 |
Norwegian | 10 |
Neutrophil | 10 |
Zhao | 10 |
NWs | 10 |
Rosa | 10 |
Populations | 10 |
Saison | 10 |
VK | 10 |
Young | 10 |
Worobey | 10 |
Sambucus | 10 |
Workers | 10 |
Work | 10 |
Winter | 10 |
Wei | 10 |
Waltham | 10 |
Wallis | 10 |
WWI | 10 |
WSN | 10 |
Victorian | 10 |
Walter | 10 |
Standaard | 10 |
Seroprevalence | 10 |
Triple | 10 |
Tests | 10 |
TX | 10 |
TWAR | 10 |
T-705 | 10 |
Synthetic | 10 |
Series | 10 |
Shenzhen | 10 |
Tucumán | 10 |
Impfstoffe | 9 |
Imai | 9 |
LCI | 9 |
IRAT | 9 |
Issues | 9 |
IL-4 | 9 |
LLC | 9 |
Kong/97 | 9 |
KAMV | 9 |
KHTV | 9 |
Kong/68 | 9 |
Krug | 9 |
IA | 9 |
IIV3 | 9 |
Guardian | 9 |
Hinshaw | 9 |
Han | 9 |
Haem | 9 |
HRSV | 9 |
HRSA | 9 |
HPIV3 | 9 |
HDU | 9 |
H7N1 | 9 |
H3N2/ | 9 |
Guo | 9 |
Guangzhou | 9 |
Greenberg | 9 |
Law | 9 |
Good | 9 |
LP | 9 |
NY/09 | 9 |
Leone | 9 |
Muench | 9 |
GRNV | 9 |
Naples | 9 |
Nanoparticle | 9 |
Nachweis | 9 |
NaCl | 9 |
NP147 | 9 |
NMR | 9 |
NIPH | 9 |
NIBRG-23 | 9 |
ND | 9 |
NAbs | 9 |
N9 | 9 |
Mycobacterium | 9 |
Mouse | 9 |
Lepus | 9 |
Mount | 9 |
Modelling | 9 |
Mice | 9 |
Metapneumovirus | 9 |
Marmara | 9 |
Market | 9 |
Map | 9 |
Major | 9 |
MO | 9 |
MEGA | 9 |
MDT | 9 |
Longini | 9 |
Local | 9 |
Gary | 9 |
AG | 9 |
GG | 9 |
Anseriformes | 9 |
CD40 | 9 |
CD-1 | 9 |
CCI | 9 |
C4 | 9 |
C1 | 9 |
Business | 9 |
Buryatia | 9 |
Burkholderia | 9 |
Buhnerkempe | 9 |
Bradford | 9 |
BIC | 9 |
Attribution | 9 |
Approach | 9 |
Anderson | 9 |
CFP | 9 |
Alliance | 9 |
Akt | 9 |
African | 9 |
AM | 9 |
AIC | 9 |
ADCC | 9 |
ACF | 9 |
AB | 9 |
A(H5N8 | 9 |
A(H10N8 | 9 |
3C | 9 |
-3 | 9 |
News | 9 |
CES3 | 9 |
CP | 9 |
GCBR | 9 |
Diagnostik | 9 |
G2 | 9 |
Fulica | 9 |
Fouchier | 9 |
FMDV | 9 |
F2 | 9 |